Baker Tilly Wealth Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$209K Buy
+1,402
New +$197K 0.04% 276
2026
Q2
– Sell
-2,712
Closed -$378K – 297
2026
Q1
$378K Sell
2,712
-140
-5% -$19.6K 0.09% 185
2025
Q4
$350K Buy
2,852
+338
+13% +$41.1K 0.09% 200
2025
Q3
$279K Buy
2,514
+106
+4% +$12K 0.06% 228
2025
Q2
$267K Buy
2,408
+108
+5% +$11.5K 0.1% 200
2025
Q1
$258K Sell
2,300
-3,273
-59% -$338K 0.1% 201
2024
Q4
$515K Sell
5,573
-735
-12% -$66.2K 0.2% 115
2024
Q3
$529K Sell
6,308
-313
-5% -$23.9K 0.23% 109
2024
Q2
$454K Sell
6,621
-10,845
-62% -$724K 0.19% 133
2024
Q1
$1.28M Sell
17,466
-567
-3% -$43.6K 0.23% 99
2023
Q4
$1.46M Buy
18,033
+8,898
+97% +$692K 0.24% 96
2023
Q3
$685K Buy
9,135
+3,441
+60% +$265K 0.11% 184
2023
Q2
$439K Buy
5,694
+128
+2% +$10.2K 0.05% 371
2023
Q1
$462K Buy
5,566
+150
+3% +$12.4K 0.05% 357
2022
Q4
$465K Sell
5,416
-2,175
-29% -$172K 0.06% 343
2022
Q3
$468K Sell
7,591
-38
-0.5% -$2.4K 0.06% 306
2022
Q2
$472K Buy
7,629
+208
+3% +$12.9K 0.06% 322
2022
Q1
$441K Sell
7,421
-916
-11% -$58.6K 0.05% 365
2021
Q4
$605K Buy
8,337
+1,620
+24% +$112K 0.06% 317
2021
Q3
$469K Buy
6,717
+782
+13% +$54.9K 0.06% 327
2021
Q2
$409K Buy
5,935
+899
+18% +$60K 0.07% 326
2021
Q1
$325K Buy
5,036
+1,454
+41% +$93.8K 0.07% 338
2020
Q4
$209K Buy
+3,582
New +$216K 0.06% 314

Other funds holding GILD

Baker Tilly Wealth Management's GILD Position: Q3 2026 in Review

Baker Tilly Wealth Management opened a new position in Gilead Sciences (GILD) in Q3 2026: 1,402 shares worth $209K. The stake represents 0.04% of the portfolio and ranks #276 among its holdings. This is a return to the name: Baker Tilly Wealth Management previously reported a position in GILD as recently as Q1 2026.

Baker Tilly Wealth Management first reported a position in GILD in Q4 2020 and has held it in 23 quarters since. The position peaked at $1.46M in Q4 2023. 119 funds tracked by Wall St. Rank hold GILD as of Q3 2026.

  • Baker Tilly Wealth Management held 1,402 shares of Gilead Sciences worth $209K as of Q3 2026.
  • Gilead Sciences was a new Baker Tilly Wealth Management position in Q3 2026.
  • Gilead Sciences made up 0.04% of Baker Tilly Wealth Management's portfolio in Q3 2026, its #276 holding.
  • Baker Tilly Wealth Management first reported a position in Gilead Sciences in Q4 2020 and has held it in 23 quarters since.
  • Baker Tilly Wealth Management's Gilead Sciences position peaked at $1.46M in Q4 2023.
  • 119 funds tracked by Wall St. Rank held Gilead Sciences as of Q3 2026.

Based on Baker Tilly Wealth Management's 13F filing for Q3 2026, filed 5 Oct 2026.